DAWN EBITDA Growth
Day One Biopharmaceuticals Inc · EBITDA Growth
DAWN EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-22.23%period ending
DAWN TTM EBITDA YoY % (-66.14% → -22.23%)
Year-over-year change
High-resolution chart · PNG
DAWN ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -22.2293% | |
| -72.3198% | |
| 47.9183% | |
| 71.6443% | |
| 54.2136% | |
| 52.7448% | |
| 0.2608% | |
| -33.4481% | |
| -33.0985% | |
| -40.803% | |
| -57.4917% | |
| -85.604% | |
| -95.2904% | |
| -43.4376% | |
| -48.5788% | |
| -45.8593% | |
| -66.1391% |